Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Adult fibroblasts help heart cells mature and improve heart function.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Finasteride may cause slight depression and anxiety.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

Lower SHBG levels may increase the risk of PCOS.

A new gene, JMJD1C, may affect testosterone levels in men.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

SHBG may be a useful early indicator and treatment target for PCOS.